ISB News

Dr. Wei Wei Awarded CARE Grant

The Andy Hill Cancer Research Endowment (CARE) announced ISB Assistant Professor Dr. Wei Wei as a CARE Fund Distinguished Researcher and awarded him $500,000.

“I am extremely honored. This is an unforgettable moment that is much bigger than me — it would not have been possible without the support of my team members, my colleagues, and my institution,” said Wei. “The award recognizes successes of the past and the promise of the future. With the generous support of the CARE fund, I will do everything I can to fight cancer.”

The Wei Lab is developing micro technologies that cultivate new understandings in fundamental cancer biology, as well as new opportunities in translational research in the clinic.

Wei is the second ISB researcher to receive grant funding distinguished researcher funding from The Andy Hill CARE Fund, a public-private partnership that supports cancer research in Washington state. ISB President Dr. Jim Heath was awarded $500,000 in December 2017.

Wei joined ISB in August. Prior to coming to Seattle, he earned his PhD from Caltech and served as a faculty member at UCLA Medical School.

Read a recent Q&A with Wei that delves into his research career, how research might change over the next decade, and his interests and hobbies when not focusing on science.

Recent Articles

  • Spotlight on ISB Education graphic

    2023-24 School Year ISB Education Highlights

    Each month throughout the 2023-2024 academic year, we will highlight some of the top projects the ISB Education team is working on. In March, ISB Education highlights include a paper published in a Nature Portfolio journal, two events for science/STEM leaders, and more.

  • STEM Program Models for Students from Historically Marginalized Communities

    A new study unveils important insights and actionable protocols into providing equitable STEM experiences for high school students from historically marginalized communities. The research highlights the transformative power of informal STEM learning and the ease with which many organizations could provide these opportunities.

  • Common Immune Response Protective Across Many Diseases

    Infection, autoimmunity and cancer account for 40 percent of deaths worldwide. In a Cell Reports paper, ISB researchers detail how the human immune system works in common ways across diseases – findings that offer promising avenues for exploring multi-disease therapeutic strategies.